Journal list menu
Export Citations
Download PDFs
Hepatopancreatobiliary Cancer
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
- First Published: 05 January 2023
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial
- First Published: 29 December 2022
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection
- First Published: 24 December 2022
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
- First Published: 30 September 2022
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study
- First Published: 09 November 2022
Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma
- First Published: 08 November 2022
Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma
- First Published: 01 October 2022
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
- First Published: 15 September 2022
Tumor-associated macrophages in liver cancer: From mechanisms to therapy
- First Published: 07 September 2022
Peripheral naïve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a biomarker study
- First Published: 22 August 2022
Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool
- First Published: 18 July 2022
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
- First Published: 07 March 2022
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
- First Published: 15 January 2022
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1
- First Published: 04 January 2022
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci
- First Published: 08 December 2021
Characterization of DNA damage response deficiency in pancreatic cancer patients from China
- First Published: 24 November 2021
Detection of pancreatic cancer by indocyanine green-assisted fluorescence imaging in the first and second near-infrared windows
- First Published: 17 November 2021
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
- First Published: 31 July 2021

Pancreatic cancer is a highly malignant digestive system tumor with poor prognosis. Most pancreatic cancer patients are diagnosed at advanced stages or even metastasis due to its highly aggressive characteristics and the lack of early typical symptoms. Thus, the early diagnosis of pancreatic cancer is crucial for improving its prognosis
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
- First Published: 15 July 2021
Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis
- First Published: 01 July 2021

We constructed one of the largest ubiquitinome dataset obtained from human cancer tissues to date using the high-resolution mass spectrometry and immunoenrichment of diGly-modified peptides. We identified a E3 ligase, SYVN1, which potentially participated in the metastasis of HCC. We studied the interaction omics of SYVN1, and found it interacted with HSP90 and impacted the ubiquitination of EEF2K.